首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
HCV COMBINATION THERAPY
摘要
The present invention relates to the treatment of hepatitis C (HCV) infection by the combination treatment with a miR-122 inhibitor and a HCV NS5B RNA dependant RNA polymerase inhibitor.
申请公布号
EP2726610(A1)
申请公布日期
2014.05.07
申请号
EP20120729147
申请日期
2012.06.25
申请人
STELLA APS
发明人
HODGES, MICHAEL
分类号
C12N15/113;A61K31/34;A61K31/4535;A61K31/495;A61K31/7115;A61K31/712;A61K31/7125;A61P31/14
主分类号
C12N15/113
代理机构
代理人
主权项
地址
您可能感兴趣的专利
Computer-aided-design of skeletal implants
Method for wireless internet communication in mobile communication terminal
Silicon carbide single crystal, silicon carbide substrate and manufacturing method for silicon carbide single crystal
Adjustment device for an accessory such as a ski binding heelpiece
Geographical web browser, methods, apparatus and systems
Method, system, and computer program product for caching web content
System and method for establishing communication between a client and a server in a heterogenous ip network
Method and system for monitoring server events in a node configuration by using direct communication between servers
High frequency module
Proxy smart card applications
Self-organization of sensor networks using ant colony optimization
Electrical appliance energy consumption control methods and electrical energy consumption systems
Transaction network
Lithium-ion battery
Polymeric substrate having a desiccant layer
Semiconductor module, process for producing the same, and film interposer
Control apparatus for an internal combustion engine
Thin ply laminates
Systems and methods for retrieval of medical data
Method for computer network operation providing basis for usage fees
